RecruitingNCT07319442

CEDUR - German IBD Registry

Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"

Sponsor

ImmunoRegister gUG

Enrollment

10,000 participants

Start Date

May 3, 2018

Study Type

OBSERVATIONAL

Conditions

Ulcerative Colitis (UC)Crohn Disease (CD)Indeterminate Colitis

Summary

The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

CEDUR is a German national registry study collecting real-world data from patients with inflammatory bowel disease (IBD) — including Crohn's disease, ulcerative colitis, and indeterminate colitis — to improve understanding and treatment of these conditions. **You may be eligible if...** - You have been diagnosed with Crohn's disease, ulcerative colitis, or indeterminate colitis **You may NOT be eligible if...** - You have a different gastrointestinal disorder that is not one of the three IBD types listed above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.